THE INCIDENCE OF GIANT-CELL ARTERITIS IN OLMSTED COUNTY, MINNESOTA - APPARENT FLUCTUATIONS IN A CYCLIC PATTERN

被引:256
作者
SALVARANI, C
GABRIEL, SE
OFALLON, WM
HUNDER, GG
机构
[1] MAYO CLIN & MAYO FDN, DEPT HLTH SCI RES, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO FDN, DIV RHEUMATOL, ROCHESTER, MN 55905 USA
关键词
D O I
10.7326/0003-4819-123-3-199508010-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate trends in the incidence of giant cell arteritis over Design: Population-based incidence study. Setting: Olmsted County, Minnesota. Methods: All incidence cases of giant cell arteritis first diagnosed between 1950 and 1991 were identified using the unified record system at Mayo Clinic. Age- and sex-specific incidence rates were calculated using the number of incidence cases as the numerator and population estimates as the denominator. Overall rates were age- and sex-adjusted to the 1980 United States. white population. The annual incidence rates were graphically illustrated using a 3-year centered moving average. Results: Between 1950 and 1998, 125 Olmsted County residents (103 women and 22 men) were diagnosed with giant cell arteritis. The age- and sex-adjusted incidence per 100 000 persons 50 years of age or older was 17.8 (95% CI, 14.1 to 21.0); incidence was significantly higher in women (24.2 [CI, 19.5 to 28.9]) than in men (8.2 [CI, 4.8 to 11.6]). Age-specific incidence rates increased with age (P < 0.0001). The annual incidence rates increased significantly over the study period (P = 0.002) and appear to have clustered in five peak periods, which occurred about every 7 years. A significant calendar-time effect was identified; it predicted an increase in incidence of 2.6% (CI, 0.9% to 4.3%) every 5 years. Conclusions: Our observation of a regular cyclic pattern in incidence rates over time supports the hypothesis of an infectious cause for giant cell arteritis. Similar studies in other populations are needed to confirm our findings.
引用
收藏
页码:192 / 194
页数:3
相关论文
共 24 条
  • [1] Anderson DW, 1991, NEUROEPIDEMIOLOGY TR, P239
  • [2] BARRIER JH, 1988, J RHEUMATOL, V15, P383
  • [3] BENGTSSON BA, 1982, ACTA MED SCAND, P1
  • [4] GIANT-CELL ARTERITIS, TEMPORAL ARTERITIS, AND POLYMYALGIA RHEUMATICA IN A DANISH COUNTY - A PROSPECTIVE INVESTIGATION, 1982-1985
    BOESEN, P
    SORENSEN, SF
    [J]. ARTHRITIS AND RHEUMATISM, 1987, 30 (03): : 294 - 299
  • [5] POLYMYALGIA RHEUMATICA - A 10-YEAR EPIDEMIOLOGIC AND CLINICAL-STUDY
    CHUANG, TY
    HUNDER, GG
    ILSTRUP, DM
    KURLAND, LT
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) : 672 - 680
  • [6] CIMMINO MA, 1993, CLIN EXP RHEUMATOL, V11, P309
  • [7] ANTIBODIES TO INTERMEDIATE FILAMENTS IN POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS - A SEQUENTIAL STUDY
    DASGUPTA, B
    DUKE, O
    KYLE, V
    MACFARLANE, DG
    HAZLEMAN, BL
    PANAYI, GS
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (10) : 746 - 749
  • [8] HEPATITIS-B VIRUS AND POLYMYALGIA RHEUMATICA - A SEARCH FOR HBSAG, HBSAB, HBCAB, HBEAG, AND HBEAB
    ELLING, H
    SKINHOJ, P
    ELLING, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1980, 39 (05) : 511 - 513
  • [9] FESSEL WJ, 1969, LANCET, V2, P1249
  • [10] FRANZEN P, 1992, J RHEUMATOL, V19, P273